Kalyani Daita

发表

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

P. Bedossa, Y. Hoshida, S. Koduru, 2016, Journal of hepatology.

An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis

G. Rosen, A. Sanyal, M. Contos, 2018, Scientific Reports.

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

H. Nittono, P. Hylemon, J. Bajaj, 2013, Journal of hepatology.

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

R. Stravitz, P. Hylemon, A. Sanyal, 2014, Alimentary pharmacology & therapeutics.

Altered profile of human gut microbiome is associated with cirrhosis and its complications.

Andmorgan R. Fisher, P. Hylemon, A. Sanyal, 2014, Journal of hepatology.

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

Andmorgan R. Fisher, H. Rangwala, P. Hylemon, 2013, PloS one.

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

P. Hylemon, J. Bajaj, P. Gillevet, 2012, American journal of physiology. Gastrointestinal and liver physiology.

The Cirrhosis Dysbiosis Ratio defines Changes in the Gut Microbiome Associated with Cirrhosis and its Complications

Andmorgan R. Fisher, P. Hylemon, A. Sanyal, 2014 .

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus

P. Hylemon, J. Bajaj, N. Betrapally, 2015, Scientific Reports.

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

P. Hylemon, A. Sanyal, J. Bajaj, 2015, Hepatology.

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

S. Taylor-Robinson, Roger Williams, I. Cox, 2014, American journal of physiology. Gastrointestinal and liver physiology.

Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese[S]

T. Vihervaara, K. Ekroos, A. Sanyal, 2016, Journal of Lipid Research.

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis

P. Hylemon, J. Bajaj, N. Betrapally, 2016, Scientific Reports.

The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

Rohit Kohli, P. Hylemon, A. Sanyal, 2018, Hepatology.

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

H. Nittono, P. Hylemon, J. Bajaj, 2013, Journal of Hepatology.

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

P. Hylemon, J. Bajaj, N. Betrapally, 2016, Alimentary pharmacology & therapeutics.

Preserved hemostatic status in patients with non-alcoholic fatty liver disease.

A. Sanyal, T. Lisman, M. Siddiqui, 2016, Journal of hepatology.